CoChat

Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease

Open access
Schmidt, Sebastian, Luecken, Malte D., Trümbach, Dietrich, Hembach, Sina, Niedermeier, Kristina M., Wenck, Nicole, Pflügler, Klaus, Stautner, Constantin, Böttcher, Anika, Lickert, Heiko, Ramirez-Suastegui, Ciro, Ahmad, Ruhel, Ziller, Michael J., Fitzgerald, Julia C., Ruf, Viktoria, van de Berg, Wilma D. J., Jonker, Allert J., Gasser, Thomas, Winner, Beate, Winkler, Jürgen, Vogt Weisenhorn, Daniela M., Giesert, Florian, Theis, Fabian J., Wurst, Wolfgang · 2022 · Nature Communications
Cited by 66

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Parkinson’s disease (PD) as a progressive neurodegenerative disorder arises from multiple genetic and environmental factors. However, underlying pathological mechanisms remain poorly understood. Using multiplexed single-cell transcriptomics, we analyze human neural precursor cells (hNPCs) from sporadic PD (sPD) patients. Alterations in gene expression appear in pathways related to primary cilia (PC). Accordingly, in these hiPSC-derived hNPCs and neurons, we observe a shortening of PC. Additionally, we detect a shortening of PC in PINK1 -deficient human cellular and mouse models of familial PD. Furthermore, in sPD models, the shortening of PC is accompanied by increased Sonic Hedgehog (SHH) signal transduction. Inhibition of this pathway rescues the alterations in PC morphology and mitochondrial dysfunction. Thus, increased SHH activity due to ciliary dysfunction may be required for the development of pathoetiological phenotypes observed in sPD like mitochondrial dysfunction. Inhibiting overactive SHH signaling may be a potential neuroprotective therapy for sPD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-32229-9

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 70

  1. Fahn, S. Description of Parkinson’s disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 991, 1–14 (2003). · DOI · Paper page
  2. Postuma, R. B. & Berg, D. Prodromal Parkinson’s Disease: The Decade Past, the Decade to Come. Mov. Disord.: Off. J. Mov. Disord. Soc. 34, 665–675 (2019). · DOI · Paper page
  3. Inamdar, N. N., Arulmozhi, D. K., Tandon, A. & Bodhankar, S. L. Parkinson’s disease: genetics and beyond. Curr. Neuropharmacol. 5, 99–113 (2007). · DOI
  4. Kalia, L. V. & Lang, A. E. Parkinson’s disease. Lancet 386, 896–912 (2015). · DOI · Paper page
  5. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006). · DOI · Paper page
  6. Carola, G. et al. Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration. NPJ Parkinson’s Dis. 7, 55 (2021). · DOI
  7. Riemens, R. J. M., Kenis, G. & van den Beucken, T. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer’s disease. Neurobiol. Learn. Mem. 175, 107318 (2020). · DOI
  8. Kouroupi, G., Antoniou, N., Prodromidou, K., Taoufik, E. & Matsas, R. Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification. Int. J. Mol. Sci. 21; https://doi.org/10.3390/ijms21197113 (2020). · DOI
  9. Popp, B. et al. Need for high-resolution Genetic Analysis in iPSC. Results and Lessons from the ForIPS Consortium. Sci. Rep. 8, 17201 (2018). · DOI · Paper page
  10. Schapira, A. H. et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J. Neurochem. 55, 2142–2145 (1990). · DOI · Paper page
  11. Navarro, A. et al. Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic. Biol. Med. 46, 1574–1580 (2009). · DOI
  12. Milanese, C. et al. Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson’s disease. Mov. Disord.: Off. J. Mov. Disord. Soc. 34, 1192–1202 (2019). · DOI
  13. Carling, P. J. et al. Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson’s disease. Prog. Neurobiol. 187, 101772 (2020). · DOI · Paper page
  14. Thomas, S. et al. Human neural crest cells display molecular and phenotypic hallmarks of stem cells. Hum. Mol. Genet. 17, 3411–3425 (2008). · DOI
  15. Nagy, N. et al. Collagen 18 and agrin are secreted by neural crest cells to remodel their microenvironment and regulate their migration during enteric nervous system development. Development (Cambridge, England) 145; https://doi.org/10.1242/dev.160317 (2018). · DOI
  16. Campanelli, J. T. et al. Expression profiling of human glial precursors. BMC Deve. Biol. 8, 102 (2008). · DOI
  17. Korzhevskii, D. E., Karpenko, M. N. & Kirik, O. V. Microtubule-Associated Proteins as Indicators of Differentiation and the Functional State of Nerve Cells. Neurosci. Behav. Physi. 42, 215–222 (2012). · DOI
  18. Ellis, P. et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev. Neurosci. 26, 148–165 (2004). · DOI · Paper page
  19. Ly, T. et al. Proteomic analysis of cell cycle progression in asynchronous cultures, including mitotic subphases, using PRIMMUS. eLife 6; https://doi.org/10.7554/eLife.27574 (2017). · DOI · Paper page
  20. Navarro Quiroz, E. et al. Cell Signaling in Neuronal Stem Cells. Cells 7; https://doi.org/10.3390/cells7070075 (2018). · DOI
  21. Mubeen, S. et al. The Impact of Pathway Database Choice on Statistical Enrichment Analysis and Predictive Modeling. Front. Genet. 10, 1203 (2019). · DOI
  22. Wright, R. Mitochondrial dysfunction and Parkinson’s disease. Nat. Neurosci. 25, 2 (2022). · doi:10.1038/s41593-021-00989-0
  23. Tucker, K. L. & Caspary, T. (eds.). Cilia and Nervous System Development and Function (Springer Netherlands, Dordrecht, 2013). · doi:10.1007/978-94-007-5808-7
  24. Malicki, J. J. & Johnson, C. A. The Cilium: Cellular Antenna and Central Processing Unit. Trends Cell Biol. 27, 126–140 (2017). · DOI · Paper page
  25. Hisahara, S. & Shimohama, S. Dopamine receptors and Parkinson’s disease. Int. J. Medicinal Chem. 2011, 403039 (2011). · DOI
  26. Singh, S. K., Gui, M., Koh, F., Yip, M. C. & Brown, A. Structure and activation mechanism of the BBSome membrane protein trafficking complex. eLife 9; https://doi.org/10.7554/eLife.53322 (2020). · DOI
  27. Chen, Y. & Jiang, J. Decoding the phosphorylation code in Hedgehog signal transduction. Cell Res. 23, 186–200 (2013). · DOI · Paper page
  28. Hui, C.-C. & Angers, S. Gli proteins in development and disease. Annu. Rev. Cell Dev. Biol. 27, 513–537 (2011). · DOI · Paper page
  29. Jacob, J. & Briscoe, J. Gli proteins and the control of spinal-cord patterning. EMBO Rep. 4, 761–765 (2003). · DOI · Paper page
  30. Carballo, G. B., Honorato, J. R., Lopes, G. P. Fde & Spohr, T. C. Ld. S. E. A highlight on Sonic hedgehog pathway. Cell Commun. Signal. 16, 11 (2018). · DOI · Paper page
  31. Pak, E. & Segal, R. A. Hedgehog Signal Transduction. Key Players, Oncogenic Drivers, and Cancer Therapy. Dev.Cell 38, 333–344 (2016). · DOI · Paper page
  32. Kotani, T. Protein kinase A activity and Hedgehog signaling pathway. Vitam. Hormones 88, 273–291 (2012). · DOI
  33. Vokes, S. A. et al. Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development 134, 1977–1989 (2007). · DOI · Paper page
  34. Jung, B. et al. Novel small molecules targeting ciliary transport of Smoothened and oncogenic Hedgehog pathway activation. Sci. Rep. 6, 22540 (2016). · DOI
  35. Das Banerjee, T. et al. PINK1 regulates mitochondrial trafficking in dendrites of cortical neurons through mitochondrial PKA. J. Neurochem. 142, 545–559 (2017). · DOI · Paper page
  36. Ferraris, A. et al. Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov. Disord.: Off. J. Mov. Disord. Soc. 24, 2350–2357 (2009). · DOI · Paper page
  37. Ricciardi, L. et al. Phenotypic variability of PINK1 expression. 12 Years’ clinical follow-up of two Italian families. Mov. Disord.: Off. J. Mov. Disord. Soc. 29, 1561–1566 (2014). · DOI · Paper page
  38. O’Flanagan, C. H., Morais, V. A., Wurst, W., Strooper, Bde & O’Neill, C. The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes. Oncogene 34, 1363–1374 (2015). · DOI
  39. Glasl, L. et al. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb. Exp. Neurol. 235, 214–227 (2012). · DOI
  40. Sánchez-Danés, A. et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol. Med. 4, 380–395 (2012). · DOI · Paper page
  41. Donega, V. et al. Transcriptome and proteome profiling of neural stem cells from the human subventricular zone in Parkinson’s disease. Acta Neuropathologica Commun. 7, 84 (2019). · DOI
  42. Laperle, A. H. et al. iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates. Nature medicine; https://doi.org/10.1038/s41591-019-0739-1 (2020). · DOI
  43. Atkinson, K. F. et al. Dopaminergic signaling within the primary cilia in the renovascular system. Front. Physiol. 6, 103 (2015). · DOI
  44. Abdul-Majeed, S. & Nauli, S. M. Dopamine receptor type 5 in the primary cilia has dual chemo- and mechano-sensory roles. Hypertension 58, 325–331 (2011). · DOI · Paper page
  45. Bae, J.-E. et al. Primary cilia mediate mitochondrial stress responses to promote dopamine neuron survival in a Parkinson’s disease model. Cell Death Dis. 10, 952 (2019). · DOI · Paper page
  46. West, A. B. & Cookson, M. R. Identification of bona-fide LRRK2 kinase substrates. Mov. Disord.: Off. J. Mov. Disord. Soc. 31, 1140–1141 (2016). · DOI
  47. Sobu, Y., Wawro, P. S., Dhekne, H. S., Yeshaw, W. M. & Pfeffer, S. R. Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins. In Proc. of the National Academy of Sciences of the United States of America 118; https://doi.org/10.1073/pnas.2005894118 (2021). · DOI · Paper page
  48. Broekhuis, J. R., Leong, W. Y. & Jansen, G. Regulation of cilium length and intraflagellar transport. Int. Rev. Cell Mol. Biol. 303, 101–138 (2013). · DOI · Paper page
  49. Jensen, V. L. et al. Role for intraflagellar transport in building a functional transition zone. EMBO Reports. 19; https://doi.org/10.15252/embr.201845862 (2018). · DOI · Paper page
  50. Wen, X. et al. Kinetics of hedgehog-dependent full-length Gli3 accumulation in primary cilia and subsequent degradation. Mol. Cell. Biol. 30, 1910–1922 (2010). · DOI · Paper page
  51. Ostasov, P. et al. Sonic Hedgehog and Triiodothyronine Pathway Interact in Mouse Embryonic Neural Stem Cells. Int. J. Mol. Sci. 21; https://doi.org/10.3390/ijms21103672 (2020). · DOI
  52. Malhotra, A., Dey, A., Prasad, N. & Kenney, A. M. Sonic Hedgehog Signaling Drives Mitochondrial Fragmentation by Suppressing Mitofusins in Cerebellar Granule Neuron Precursors and Medulloblastoma. Mol. Cancer Res.: MCR 14, 114–124 (2016). · DOI
  53. Perier, C. & Vila, M. Mitochondrial biology and Parkinson’s disease. Cold Spring Harb. Perspect. Med. 2, a009332 (2012). · DOI · Paper page
  54. Mounsey, R. B. & Teismann, P. Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and neuroprotection. Parkinson’s Dis. 2011, 617472 (2010).
  55. Prasuhn, J., Davis, R. L. & Kumar, K. R. Targeting Mitochondrial Impairment in Parkinson’s Disease: Challenges and Opportunities. Front. Cell Dev. Biol. 8, 615461 (2020). · DOI
  56. Carpenter, R. L. & Ray, H. Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer. Drug Saf. 42, 263–279 (2019). · DOI
  57. Shao, S. et al. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson’s disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway. Mol. Med. Rep. 16, 1269–1277 (2017). · DOI
  58. Bus, C. et al. Human Dopaminergic Neurons Lacking PINK1 Exhibit Disrupted Dopamine Metabolism Related to Vitamin B6 Co-Factors. iScience 23, 101797 (2020). · DOI
  59. Reinhardt, P. et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PloS One. 8, e59252 (2013). · DOI · Paper page
  60. Schindelin, J. et al. Fiji. An open-source platform for biological-image analysis. Nat. methods 9, 676–682 (2012). · DOI · Paper page
  61. Guo, Y. et al. Illumina human exome genotyping array clustering and quality control. Nat. Protoc. 9, 2643–2662 (2014). · DOI · Paper page
  62. Chang, C. C. et al. Second-generation PLINK. Rising to the challenge of larger and richer datasets. GigaSci. 4, 7 (2015). · DOI · Paper page
  63. Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY. Large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018). · DOI · Paper page
  64. Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 352, 189–196 (2016). · DOI · Paper page
  65. Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008). · DOI · Paper page
  66. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000). · DOI · Paper page
  67. Strimmer, K. fdrtool. A versatile R package for estimating local and tail area-based false discovery rates. Bioinforma. 24, 1461–1462 (2008). · DOI · Paper page
  68. Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler. An R package for comparing biological themes among gene clusters. Omics: A J. Integr. Biol. 16, 284–287 (2012). · DOI · Paper page
  69. Cartharius, K. et al. MatInspector and beyond. Promoter Anal. based transcription factor binding sites. Bioinforma. 21, 2933–2942 (2005). · DOI · Paper page
  70. Chen, H. & Boutros, P. C. VennDiagram. A package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinforma. 12, 35 (2011). · DOI · Paper page

Cited by

See all 66

Metadata

Authors
Schmidt, S., Luecken, M. D., Trümbach, D., Hembach, S., Niedermeier, K. M., Wenck, N., Pflügler, K., Stautner, C., Böttcher, A., Lickert, H., Ramirez-Suastegui, C., Ahmad, R., Ziller, M. J., Fitzgerald, J. C., Ruf, V., van de Berg, W. D. J., Jonker, A. J., Gasser, T., Winner, B., Winkler, J., Vogt Weisenhorn, D. M., Giesert, F., Theis, F. J., & Wurst, W.
Venue
Nature Communications
Published
2022-08-16
Volume
13
Issue
1
Pages
4819-4819
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4292066000
Cited by
66
References
31
FWCI
6.10
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease. https://app.cochat.ai/papers/10.1038/s41467-022-32229-9
The paper
Schmidt, S., Luecken, M. D., Trümbach, D., Hembach, S., Niedermeier, K. M., Wenck, N., Pflügler, K., Stautner, C., Böttcher, A., Lickert, H., Ramirez-Suastegui, C., Ahmad, R., Ziller, M. J., Fitzgerald, J. C., Ruf, V., van de Berg, W. D. J., Jonker, A. J., Gasser, T., Winner, B., . . . Wurst, W. (2022). Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease. Nature Communications. https://doi.org/10.1038/s41467-022-32229-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.